Abstract
The objective of this study was to understand pain treatment utilization, perceived efficacy, and differences in utilization by gender, clinic site, chronicity of pain, pain severity, and depression severity among people living with HIV (PLWH), chronic pain, and elevated depression symptoms. Participants included 187 PLWH at three HIV clinics in the U.S. Overall, 85% of participants reported taking a pain medication. One quarter (25%) reported non-pharmacological professional treatments for pain (e.g., massage, physical therapy), 60% reported mind–body treatments, including exercise, meditation, and yoga, and 62% reported other non-pharmacological self-administered treatments (e.g., heat/cold). Most pain treatments were considered “slightly helpful” or “moderately helpful.” Non-pharmacological self-administered treatments were more commonly used among women than men and among individuals with constant vs. intermittent pain. Further research is needed to evaluate the efficacy of the preferred analgesic modalities of PLWH.
Similar content being viewed by others
Availability of Data and Material
Data are available from corresponding author upon reasonable request.
Code Availability
The SPSS code to conduct this statistical analysis presented in this paper is available upon reasonable request to the authors.
References
Treede R-D, Rief W, Barke A, et al. A classification of chronic pain for ICD-11. Pain. 2015;156(6):1003–7. https://doi.org/10.1097/j.pain.0000000000000160.
Cervia LD, McGowan JP, Weseley AJ. Clinical and demographic variables related to pain in HIV-infected individuals treated with effective, combination antiretroviral therapy (cART). Pain Med. 2010;11(4):498–503. https://doi.org/10.1111/j.1526-4637.2010.00802.x.
Dobalian A, Tsao JCI, Duncan RP. Pain and the use of outpatient services among persons with HIV: results from a nationally representative survey. Med Care. 2004;42(2):129–38. https://doi.org/10.1097/01.mlr.0000108744.45327.d4.
Lee KA, Gay C, Portillo CJ, et al. Symptom experience in HIV-infected adults: a function of demographic and clinical characteristics. J Pain Symptom Manag. 2009;38(6):882–93. https://doi.org/10.1016/j.jpainsymman.2009.05.013.
Merlin JS, Cen L, Praestgaard A, et al. Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era. J Pain Symptom Manage. 2012;43(3):638–45. https://doi.org/10.1016/j.jpainsymman.2011.04.019.
Newshan G, Bennett J, Holman S. Pain and other symptoms in ambulatory HIV patients in the age of highly active antiretroviral therapy. J Assoc Nurses AIDS Care. 2002;13(4):78–83. https://doi.org/10.1016/S1055-3290(06)60373-7.
Tsao JCI, Soto T. Pain in persons living with HIV and comorbid psychologic and substance use disorders. Clin J Pain. 2009;25(4):307–12. https://doi.org/10.1097/AJP.0b013e31819294b7.
Berg KM, Cooperman NA, Newville H, Arnsten JH. Self-efficacy and depression as mediators of the relationship between pain and antiretroviral adherence. AIDS Care. 2009;21(2):244–8. https://doi.org/10.1080/09540120802001697.
Pullen S. Physical therapy as non-pharmacological chronic pain management of adults living with HIV: self-reported pain scores and analgesic use. HIVAIDS Res Palliat Care. 2017;9:177–82. https://doi.org/10.2147/HIV.S141903.
Pullen SD, del Rio C, Brandon D, et al. Associations between chronic pain, analgesic use and physical therapy among adults living with HIV in Atlanta, Georgia: a retrospective cohort study. AIDS Care. 2020;32(1):65–71. https://doi.org/10.1080/09540121.2019.1661950.
Hillier SL, Louw Q, Morris L, Uwimana J, Statham S. Massage therapy for people with HIV/AIDS. Cochrane HIV/AIDS Group, ed. Cochrane Database Syst Rev. 2010. https://doi.org/10.1002/14651858.CD007502.pub2
Uebelacker LA, Weisberg RB, Herman DS, et al. Pilot randomized trial of collaborative behavioral treatment for chronic pain and depression in persons living with HIV/AIDS. AIDS Behav. 2016;20(8):1675–81. https://doi.org/10.1007/s10461-016-1397-7.
Cucciare MA, Sorrell JT, Trafton JA. Predicting response to cognitive-behavioral therapy in a sample of HIV-positive patients with chronic pain. J Behav Med. 2009;32(4):340–8. https://doi.org/10.1007/s10865-009-9208-5.
Trafton JA, Sorrell JT, Holodniy M, et al. Outcomes associated with a cognitive-behavioral chronic pain management program implemented in three public HIV primary care clinics. J Behav Health Serv Res. 2012;39(2):158–73. https://doi.org/10.1007/s11414-011-9254-y.
Nkhoma K, Seymour J, Arthur A. An educational intervention to reduce pain and improve pain management for Malawian people living with HIV/AIDS and their family carers: study protocol for a randomised controlled trial. Trials. 2013;14(1):216. https://doi.org/10.1186/1745-6215-14-216.
Dorfman D, George MC, Schnur J, Simpson DM, Davidson G, Montgomery G. Hypnosis for treatment of HIV neuropathic pain: a preliminary report. Pain Med. 2013;14(7):1048–56. https://doi.org/10.1111/pme.12074.
Langenfeld MC, Cipani E, Borckardt JJ. Hypnosis for the control of HIV/AIDS-related pain. Int J Clin Exp Hypn. 2002;50(2):170–88. https://doi.org/10.1080/00207140208410097.
Bonadies V. A yoga therapy program for AIDS-related pain and anxiety: implications for therapeutic recreation. Ther Recreation J. 2004;38(2):148–66.
Dunne EM, Balletto BL, Donahue ML, et al. The benefits of yoga for people living with HIV/AIDS: a systematic review and meta-analysis. Complement Ther Clin Pract. 2019;34:157–64. https://doi.org/10.1016/j.ctcp.2018.11.009.
Maharaj SS, Yakasai AM. Does a rehabilitation program of aerobic and progressive resisted exercises influence HIV-induced distal neuropathic pain? Am J Phys Med Rehabil. 2018;97(5):364–9. https://doi.org/10.1097/PHM.0000000000000866.
Mkandla K, Myezwa H, Musenge E. The effects of progressive-resisted exercises on muscle strength and health-related quality of life in persons with HIV-related poly-neuropathy in Zimbabwe. AIDS Care. 2016;28(5):639–43. https://doi.org/10.1080/09540121.2015.1125418.
Parker R, Jelsma J, Stein DJ. Managing pain in women living with HIV/AIDS: a randomized controlled trial testing the effect of a six-week peer-led exercise and education intervention. J Nerv Ment Dis. 2016;204(9):665–72. https://doi.org/10.1097/NMD.0000000000000506.
Clifford DB, Simpson DM, Brown S, et al. A randomized, double-blind, controlled study of ngx-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy. JAIDS J Acquir Immune Defic Syndr. 2012;59(2):126–33. https://doi.org/10.1097/QAI.0b013e31823e31f7.
Paice JA, Ferrans CE, Lashley FR, Shott S, Vizgirda V, Pitrak D. Topical capscaicin in the management of HIV-associated peripheral neuropathy. J Pain Symptom Manag. 2000;19(1):45–52. https://doi.org/10.1016/s0885-3924(99)00139-6.
Simpson DM, Brown S, Tobias J. For the NGX-4010 C107 Study Group. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology. 2008;70(24):2305–2313. https://doi.org/10.1212/01.wnl.0000314647.35825.9c
Hahn K, Arendt G, Braun JS, et al. A placebo-controlled trial of gabapentin for painful HIV-associated sensory neuropathies. J Neurol. 2004;251(10):1260–6. https://doi.org/10.1007/s00415-004-0529-6.
Simpson DM, Schifitto G, Clifford DB, et al. Pregabalin for painful HIV neuropathy: a randomized, double-blind, placebo-controlled trial. Neurology. 2010;74(5):413–20. https://doi.org/10.1212/WNL.0b013e3181ccc6ef.
Newshan G, Lefkowitz M. Transdermal Fentanyl for chronic pain in AIDS. J Pain Symptom Manage. 2001;21(1):69–77. https://doi.org/10.1016/S0885-3924(00)00238-4.
Abrams DI, Jay CA, Shade SB, et al. Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial. Neurology. 2007;68(7):515–21. https://doi.org/10.1212/01.wnl.0000253187.66183.9c.
Ellis RJ, Toperoff W, Vaida F, et al. Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial. Neuropsychopharmacology. 2009;34(3):672–80. https://doi.org/10.1038/npp.2008.120.
Anastasi JK, Capili B, McMahon DJ, Scully C. Acu/moxa for distal sensory peripheral neuropathy in HIV: a randomized control pilot study. J Assoc Nurses AIDS Care. 2013;24(3):268–75. https://doi.org/10.1016/j.jana.2012.09.006.
Shlay JC. Acupuncture and Amitriptyline for pain due to HIV-related peripheral neuropathy: a randomized controlled trial. JAMA. 1998;280(18):1590. https://doi.org/10.1001/jama.280.18.1590.
Dinat N, Marinda E, Moch S, Rice ASC, Kamerman PR. Randomized, double-blind, crossover trial of amitriptyline for analgesia in painful HIV-associated sensory neuropathy. Chung MH, ed. PLoS ONE. 2015;10(5):e0126297. https://doi.org/10.1371/journal.pone.0126297
Kieburtz K, Simpson D, Yiannoutsos C, et al. A randomized trial of amitriptyline and mexiletine for painful neuropathy in HIV infection. AIDS Clinical Trial Group 242 Protocol Team. Neurology. 1998;51(6):1682–1688. https://doi.org/10.1212/wnl.51.6.1682
Kemper CA, Kent G, Burton S, Deresinski SC. Mexiletine for HIV-infected patients with painful peripheral neuropathy: a double-blind, placebo-controlled, crossover treatment trial. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19(4):367–72. https://doi.org/10.1097/00042560-199812010-00007.
McArthur JC, Yiannoutsos C, Simpson DM, et al. A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection. Neurology. 2000;54(5):1080–8. https://doi.org/10.1212/WNL.54.5.1080.
Youle M, Osio M, on behalf of the ALCAR Study Group. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl l-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV Med. 2007;8(4):241–250. doi:https://doi.org/10.1111/j.1468-1293.2007.00467.x
Estanislao L, Carter K, McArthur J, Olney R, Simpson D. A randomized controlled trial of 5% lidocaine gel for HIV-associated distal symmetric polyneuropathy. JAIDS J Acquir Immune Defic Syndr. 2004;37(5):1584–6. https://doi.org/10.1097/00126334-200412150-00010.
Schifitto G, Yiannoutsos C, Simpson D, et al. A placebo-controlled study of memantine for the treatment of human immunodeficiency virus–associated sensory neuropathy. J Neurovirol. 2006;12(4):328–31. https://doi.org/10.1080/13550280600873835.
Simpson DM, Olney R, McArthur JC, Khan A, Godbold J, Ebel-Frommer K. A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy. Neurology. 2000;54(11):2115–9. https://doi.org/10.1212/wnl.54.11.2115.
Simpson DM, McArthur JC, Olney R, et al. Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial. Neurology. 2003;60(9):1508–14. https://doi.org/10.1212/01.WNL.0000063304.88470.D9.
Simpson DM, Dorfman D, Olney RK, et al. Peptide T in the treatment of painful distal neuropathy associated with AIDS: results of a placebo-controlled trial. Neurology. 1996;47(5):1254–9. https://doi.org/10.1212/WNL.47.5.1254.
Evans SR, Simpson DM, Kitch DW, et al. A Randomized Trial Evaluating ProsaptideTM for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. Tashima K, ed. PLoS ONE. 2007;2(7):e551. https://doi.org/10.1371/journal.pone.0000551
Merlin JS, Bulls HW, Vucovich LA, Edelman EJ, Starrels JL. Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review. AIDS Care. 2016;28(12):1506–15. https://doi.org/10.1080/09540121.2016.1191612.
Amaniti A, Sardeli C, Fyntanidou V, et al. Pharmacologic and non-pharmacologic interventions for HIV-neuropathy pain: a systematic review and a meta-analysis. Medicina (Mex). 2019;55(12):762. https://doi.org/10.3390/medicina55120762.
Merlin JS, Young SR, Johnson MO, et al. Using patient perspectives to inform the development of a behavioral intervention for chronic pain in patients with HIV: a qualitative study. Pain Med. 2016. https://doi.org/10.1093/pm/pnw150.
Cleeland C. The Brief Pain Inventory, Users Guide. Published online 2009.
Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573–83. https://doi.org/10.1016/S0006-3223(02)01866-8.
Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578–89. https://doi.org/10.1016/j.joca.2019.06.011.
Cooney GM, Dwan K, Greig CA, et al. Exercise for depression. Cochrane Common Mental Disorders Group, ed. Cochrane Database Syst Rev. 2013. https://doi.org/10.1002/14651858.CD004366.pub6
Marquez DX, Aguiñaga S, Vásquez PM, et al. A systematic review of physical activity and quality of life and well-being. Transl Behav Med. 2020;10(5):1098–109. https://doi.org/10.1093/tbm/ibz198.
Qaseem A, Wilt TJ, McLean RM, Forciea MA, for the Clinical Guidelines Committee of the American College of Physicians. Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(7):514. https://doi.org/10.7326/M16-2367.
Skelly AC, Chou R, Dettori JR, et al. Noninvasive Nonpharmacological Treatment for Chronic Pain: A Systematic Review Update. Agency for Healthcare Research and Quality (US); 2020. Accessed November 19, 2020. http://www.ncbi.nlm.nih.gov/books/NBK556229/
Ward L, Stebbings S, Cherkin D, Baxter GD. Yoga for functional ability, pain and psychosocial outcomes in musculoskeletal conditions: a systematic review and meta-analysis. Musculoskeletal Care. 2013;11(4):203–17. https://doi.org/10.1002/msc.1042.
Fisher E, Moore RA, Fogarty AE, et al. Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials. Pain. 2020. https://doi.org/10.1097/j.pain.0000000000001929.
Johal H, Devji T, Chang Y, Simone J, Vannabouathong C, Bhandari M. Cannabinoids in chronic non-cancer pain: a systematic review and meta-analysis. Clin Med Insights Arthritis Musculoskelet Disord. 2020;13:117954412090646. https://doi.org/10.1177/1179544120906461.
Saper RB, Sherman KJ, Delitto A, et al. Yoga vs. physical therapy vs. education for chronic low back pain in predominantly minority populations: Study protocol for a randomized controlled trial. Trials. 2014;15(1):67. https://doi.org/10.1186/1745-6215-15-67.
Ambrose KR, Golightly YM. Physical exercise as non-pharmacological treatment of chronic pain: why and when. Best Pract Res Clin Rheumatol. 2015;29(1):120–30. https://doi.org/10.1016/j.berh.2015.04.022.
Campbell LC, Clauw DJ, Keefe FJ. Persistent pain and depression: a biopsychosocial perspective. Biol Psychiatry. 2003;54(3):399–409. https://doi.org/10.1016/S0006-3223(03)00545-6.
Nicolson SE, Caplan JP, Williams DE, Stern TA. Comorbid pain, depression, and anxiety: multifaceted pathology allows for multifaceted treatment. Harv Rev Psychiatry. 2009;17(6):407–20. https://doi.org/10.3109/10673220903463226.
Teychenne M, Ball K, Salmon J. Physical activity and likelihood of depression in adults: a review. Prev Med. 2008;46(5):397–411. https://doi.org/10.1016/j.ypmed.2008.01.009.
Zou L, Yeung A, Li C, et al. Effects of meditative movements on major depressive disorder: a systematic review and meta-analysis of randomized controlled trials. J Clin Med. 2018;7(8):195. https://doi.org/10.3390/jcm7080195.
Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: Combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217–26. https://doi.org/10.1097/MLR.0b013e3182408812.
Funding
This work was supported by the National Institute of Nursing Research, US National Institutes of Health, under Grant # R01NR015977.
Author information
Authors and Affiliations
Contributions
LU, AB, JB, MP, CC, and MS contributed to the conceptualization and methodology. NG and SM contributed to material preparation and data collection. LU and EC conducted formal analysis and writing of the original draft. All authors reviewed and edited the paper, and read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Dr. Uebelacker’s spouse is employed by Abbvie Pharmaceuticals. The other authors have no relevant financial or non-financial interests to disclose.
Ethical approval
Ethical approval for research involving human participants was obtained Butler Hospital, Miriam Hospital, and Boston Medical Center Institutional Review Boards. This study was performed in accordance the 1964 Declaration of Helsinki and its later amendments.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Uebelacker, L.A., Cherenack, E.M., Busch, A. et al. Pharmacologic and Non-Pharmacologic Treatments for Chronic Pain Used by Patients with Pain, HIV, and Depression. AIDS Behav 26, 864–873 (2022). https://doi.org/10.1007/s10461-021-03447-x
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-021-03447-x